封面
市场调查报告书
商品编码
1972758

聚砜透析器市场:依透析器类型、灭菌方法、膜结构、通路和最终用户划分-2026-2032年全球预测

Polysulfone Dialyzer Market by Dialyzer Type, Sterilization Method, Membrane Configuration, Distribution Channel, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年,聚砜透析器市场价值将达到 13.9 亿美元,到 2026 年将成长至 15.7 亿美元,到 2032 年将达到 32.6 亿美元,年复合成长率为 12.84%。

主要市场统计数据
基准年 2025 13.9亿美元
预计年份:2026年 15.7亿美元
预测年份 2032 32.6亿美元
复合年增长率 (%) 12.84%

本文重点介绍聚砜透析器的基本特性与市场相关性,整合材料优势、临床需求与采购重点,供决策者参考。

聚砜透析器是材料科学、临床实践和医疗保健系统采购的交叉领域。过去十年,这些透析器凭藉其生物相容性、机械强度和可靠的清除性能,已成为体外治疗的必备工具。本文概述了聚砜为何仍然是首选的膜材料,产品在效率和通量分布方面的差异化趋势,并提供了一个讨论框架,阐述了相关人员(从临床医生到供应链经理)在评估透析器产品组合时,为何必须同时考虑临床结果和物流实际情况。

临床创新、医疗服务模式的转变以及不断发展的供应链正在全面重塑透析机产业的竞争格局和产品设计重点。

肾臟替代治疗设备领域正经历变革性的转变,这主要得益于临床创新、医疗服务模式的转变以及供应链的重组。膜工程技术的进步催生了新型透析器,这些透析器能够优化溶质清除并最大限度地减少发炎反应,迫使临床医生改进处方模式,并将更精细的设备选择纳入个别化的治疗方案中。同时,合适的透析治疗正加速从医疗机构转移到居家照护,这促使人们对兼具易用性和稳定性能的设备产生了浓厚的兴趣。反过来,这也对製造商提出了新的产品设计和培训需求。

本检验了2025 年美国实施的贸易政策变化如何影响整个聚砜透析器价值链的成本结构、筹资策略和购买行为。

美国于2025年实施的关税措施和贸易政策变化对聚砜透析器生态系统产生了累积影响,改变了投入成本、采购决策和下游采购惯例。依赖国际供应链取得聚砜原料、组件和灭菌服务的製造商面临更高的到岸成本和供应商前置作业时间更大的波动,迫使他们重新评估库存策略和合约条款。因此,一些製造商正在加快近岸外包投资,并探索替代供应商合同,以恢復利润稳定性并降低受贸易政策週期的影响。

基于细分市场的洞察,将透析器产品特性、灭菌方法、通路和最终用户需求与市场定位中的实际差异化因素联繫起来。

对细分市场绩效的详细分析表明,当产品按设备特性、终端用户环境、分销方式、灭菌方法和膜结构进行分类时,可以清楚地找到价值创造的路径。根据透析器类型,市场环境可分为传统透析器、高效率透析器和高通量透析器。传统透析器可细分为低通量和中通量两种类型,高效透析器可细分为标准效率和超高效两种类型,高通量透析器可细分为标准高通量和超高通量两种类型。这些区分至关重要,因为它们决定了每种透析器在医疗机构治疗方案组合中的定位,而这取决于临床通讯协定、治疗时间长度和溶质清除目标。

该分析整合了美洲、欧洲、中东和非洲以及亚太地区的商业性、监管和基础设施趋势,有助于制定针对每个市场的市场进入和扩大策略。

区域趋势持续对产品策略、监管合规和商业性执行产生重大影响。在美洲,成熟的临床通讯协定、整合的采购集团以及私人保险公司的积极参与,共同创造了一个环境,​​在这种环境下,产品差异化、循证实践和服务水平保障是获得长期合约的关键。该地区的医疗服务提供者重视可验证的临床结果和生命週期成本的透明度,能够提供强有力的上市后监测和快速现场支援的供应商更具优势。

以製造规模、材​​料创新和综合服务为中心的竞争与合作型企业策略将决定企业的长期商业性韧性。

材料科学、生产规模化、监管灵活性和综合服务交付能力正在重新定义主要企业与新兴企业之间的竞争格局。拥有深厚生产基础的老牌製造商在单位成本控制和分销网络覆盖方面保持优势,而专业技术公司则透过膜创新、涂层化学和专有灭菌改造技术脱颖而出,从而带来临床或物流方面的优势。新参与企业通常会瞄准特定的临床应用情境和护理环境,例如家庭透析和辅助生活项目。在这些领域,模组化产品设计和简化的使用者介面可以减轻培训负担,促进产品推广应用。

为製造商和供应商制定可操作且优先的行动方案,以协调产品创新、供应链韧性和通路策略,从而建立可持续的竞争优势。

产业领导者应采取多管齐下的策略,整合产品创新、供应链韧性和上市时间柔软性。首先,优先投资于符合人体工学的薄膜和设备设计,以直接改善临床医师的工作流程,提升病患在医疗机构和居家照护环境中的舒适度,进而降低推广应用的门槛。其次,实现采购和灭菌伙伴关係关係的多元化,以建立冗余机制,降低政策主导的成本衝击风险。最后,建立商业性可行性的区域性製造或合约製造安排,以缩短前置作业时间,并提高应对力。

我们采用透明的基于三角测量的调查方法,结合对临床医生的访谈、监管和技术审查以及情境分析,以确保研究结果的稳健性和可重复性。

本研究采用系统性的调查方法,整合一手和二手讯息,强调检验、三角测量和可重复性。一手资讯包括对关键地区临床医生、采购经理和分销合作伙伴的结构化访谈,以及对构成技术声明基础的监管申报文件、灭菌通讯协定和生产工艺文件的实证审查。二级资讯来源包括对膜性能的同行评审文献、关于透析最佳实践的公共指南以及与贸易和医疗设备法规相关的政策文件的分析,并阐述其战略意义。

对关键策略结论的简要总结,清楚地表明了为什么产品、供应链和服务一体化的方法对于在不断发展的透析器市场取得成功至关重要。

总之,聚砜透析器凭藉其卓越的临床性能和便利的生产工艺,仍然是透析治疗的基础。市场格局正受到多种因素的共同影响而重塑,包括对优化清除率和生物相容性的临床需求、居家护理的兴起、分销和灭菌方法的进步,以及政策主导的供应链调整。那些将产品创新与实证医学结果相结合、投资于供应链韧性并製定针对特定终端用户环境的分销和培训策略的企业,将在不断变化的市场环境中蓬勃发展。

目录

第一章:序言

第二章:调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵,2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章:美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

第八章:聚砜透析器市场(依透析器类型分类)

  • 传统透析器
    • 低通量透析器
    • 中通量透析器
  • 高效透析器
    • 标准效率透析器
    • 超高效透析器
  • 高通量透析器
    • 标准高通量透析器
    • 超高通量透析器

第九章:聚砜透析器市场依灭菌方法划分

  • 环氧乙烷灭菌
  • 伽玛射线灭菌
    • 高剂量伽玛射线灭菌
    • 低剂量伽马射线灭菌
  • 蒸气灭菌

第十章:按膜成分分類的聚砜透析器市场

  • 平板
    • 板框
    • 螺旋缠绕式
  • 中空纤维型
    • 多流明
    • 单流明

第十一章:聚砜透析器市场:依分销管道划分

  • 直销
  • 线上管道
  • 第三方经销商
    • 医疗设备供应商
    • 零售药房

第十二章聚砜透析器市场:依最终用户划分

  • 透析中心
  • 居家照护环境
    • 居家护理支援服务
    • 自我管理
  • 医院

第十三章:聚砜透析器市场:依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章聚砜透析器市场:依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章:聚砜透析器市场:依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章:美国聚砜透析器市场

第十七章:中国聚砜透析器市场

第十八章 竞争情势

  • 市场集中度分析,2025年
    • 浓度比(CR)
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析,2025 年
  • 2025年产品系列分析
  • 基准分析,2025 年
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Jafron Biomedical Co., Ltd.
  • JMS Co., Ltd.
  • MEDICA SpA
  • Nipro Corporation
  • Nipro Corporation
  • Poly Medicure Limited
  • Terumo Corporation
  • Toray Industries, Inc.
Product Code: MRR-9A6A6F297DBA

The Polysulfone Dialyzer Market was valued at USD 1.39 billion in 2025 and is projected to grow to USD 1.57 billion in 2026, with a CAGR of 12.84%, reaching USD 3.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.39 billion
Estimated Year [2026] USD 1.57 billion
Forecast Year [2032] USD 3.26 billion
CAGR (%) 12.84%

A focused orientation to polysulfone dialyzer fundamentals and market relevance that synthesizes material strengths, clinical needs, and procurement priorities for decision-makers

Polysulfone dialyzers sit at the intersection of material science, clinical practice, and health system procurement. Over the last decade, their combination of biocompatibility, mechanical strength, and reliable clearance characteristics has established them as a mainstay in extracorporeal therapy. This introduction frames the conversation by outlining why polysulfone remains a preferred membrane material, how product differentiation is occurring across efficiency and flux profiles, and why stakeholders from clinicians to supply chain managers must consider both clinical outcomes and logistical realities when evaluating dialyzer portfolios.

Transitioning from material properties to market implications, the subsequent analysis situates polysulfone dialyzers within contemporary trends: an aging patient population with rising chronic kidney disease prevalence, pressure to shift suitable patients to home-based therapies, and heightened scrutiny of device lifecycle costs. These forces shape procurement strategy and clinical adoption curves. Consequently, a rigorous understanding of device types, sterilization methods, membrane configurations, and distribution pathways is essential for decision-makers seeking to balance patient outcomes, regulatory compliance, and financial sustainability.

How clinical innovation, care delivery migration, and supply chain evolution are collectively reshaping competitive dynamics and product design priorities in the dialyzer field

The landscape for renal replacement devices is undergoing transformative shifts driven by clinical innovation, care-delivery migration, and supply chain reengineering. Advances in membrane engineering have produced dialyzers that optimize solute clearance while minimizing inflammatory response, prompting clinicians to refine prescription patterns and integrate more nuanced device selection into individualized care plans. Simultaneously, the migration of suitable dialysis therapies from in-center units to home care settings has accelerated interest in devices that combine ease of use with consistent performance, creating new product design and training imperatives for manufacturers.

On the supply side, distribution and sterilization modalities are adapting to meet demand for rapid replenishment and regulatory traceability. Online and direct-to-provider channels are gaining traction alongside traditional third-party distributors, while sterilization choices-ranging from ethylene oxide to gamma and steam-affect inventory handling, shelf-life considerations, and cost structures. Taken together, these shifts are reshaping competitive dynamics: companies that integrate clinical evidence, scalable manufacturing, and responsive channel strategies are positioned to capture differentiated value across care settings.

An examination of how 2025 trade policy shifts in the United States have altered cost structures, sourcing strategies, and procurement behavior across the polysulfone dialyzer value chain

The imposition of tariffs and trade policy changes in the United States during 2025 has exerted a cumulative effect on the polysulfone dialyzer ecosystem by altering input costs, sourcing decisions, and downstream procurement practices. Manufacturers that rely on international supply chains for raw polysulfone resin, components, or sterilization services have confronted increased landed costs and greater volatility in supplier lead times, which in turn has forced reassessment of inventory strategies and contract terms. As a result, some producers accelerated nearshoring investments or sought alternative vendor arrangements to restore margin stability and reduce exposure to trade-policy cycles.

For health systems and distributors, the tariff environment heightened attention to total landed cost and contract flexibility. Purchasing teams extended horizon planning for capital and consumable procurement, prioritized multi-supplier contracts, and emphasized supplier transparency around cost drivers. At the same time, sterilization workflows experienced indirect impacts: differential tariff effects on sterilization equipment and consumables influenced decisions between ethylene oxide, gamma, and steam processes based on availability, turnaround time, and regulatory compliance costs. Longer term, these policy shifts prompted manufacturers to re-evaluate pricing strategies, invest in supply-chain resilience, and accelerate product differentiation efforts that could justify premium positioning despite upward pressure on cost structures.

Segmentation-driven insights that map dialyzer product attributes, sterilization choices, distribution channels, and end-user needs into actionable differentiators for market positioning

A nuanced reading of segment performance reveals distinct pathways for value creation when products are parsed by device characteristics, end-user environment, distribution mode, sterilization approach, and membrane architecture. Based on dialyzer type, the landscape spans Conventional Dialyzers, High-Efficiency Dialyzers, and High-Flux Dialyzers, with Conventional offerings differentiated further into Low-Flux and Medium-Flux variants, High-Efficiency split between Standard and Ultra Efficiency approaches, and High-Flux categorized into Standard High-Flux and Super High-Flux tiers. These distinctions matter because clinical protocols, session duration, and solute removal objectives determine where each type fits within a provider's therapy mix.

End-user segmentation clarifies where adoption pressure is concentrated: dialysis centers, home care settings, and hospitals each exhibit different operational constraints and purchasing models, and the home setting itself bifurcates between assisted home care and self-care models that carry divergent device usability and training requirements. Distribution pathways influence time-to-clinic and service expectations, where direct sales, online channels, and third-party distributors-further segmented into medical equipment suppliers and retail pharmacy networks-play complementary roles in market reach and post-sale support. Sterilization method considerations, including ethylene oxide, gamma (with high dose and low dose distinctions), and steam processes, affect inventory turnover, regulatory documentation, and shelf-life decisions. Finally, membrane configuration-flat sheet versus hollow fiber, with further splits across plate and frame, spiral wound, multi lumen, and single lumen designs-drives manufacturing complexity and clinical handling procedures. Understanding these interlocking segments enables companies to tailor product design, training programs, and service models to the operational realities of each channel and care setting.

A regional synthesis of commercial, regulatory, and infrastructure dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that informs tailored market entry and scaling strategies

Regional dynamics continue to exert a strong influence on product strategy, regulatory compliance, and commercial execution. In the Americas, mature clinical protocols, consolidated purchasing groups, and active private payor participation create an environment where product differentiation, evidence generation, and service-level guarantees are critical to securing long-term contracts. Providers in this region place a premium on demonstrable clinical outcomes and lifecycle cost transparency, which favors suppliers that can provide robust post-market surveillance and responsive field support.

Europe, the Middle East & Africa present a heterogeneous mix of reimbursement models, regulatory timelines, and infrastructure maturity. In several European markets, centralized procurement and stringent regulatory pathways reward clinical data and cost-effectiveness narratives, whereas emerging markets within the broader region emphasize affordability and supply-chain reliability. Across these territories, varying access to sterilization infrastructure and distribution networks shapes localization strategies. In the Asia-Pacific region, diverse market maturity ranges from advanced clinical adoption in some urban centers to rapidly expanding dialysis access in other areas. Manufacturers operating here must reconcile the need for scalable, cost-efficient products with localized training and service frameworks, while also navigating variable regulatory regimes and import policies that influence commercial rollout timing.

Competitive and collaborative company strategies centered on manufacturing scale, materials innovation, and integrated services that determine long-term commercial resilience

Competitive dynamics among leading firms and emerging players are being redefined by capabilities in materials science, manufacturing scale-up, regulatory agility, and integrated service offerings. Established producers with deep manufacturing footprints maintain advantages in unit-cost management and distribution network reach, while specialist technology players differentiate through membrane innovation, coating chemistries, or proprietary sterilization adaptations that deliver clinical or logistical benefits. New entrants often target niche clinical use-cases or care settings-such as home dialysis or assisted-care programs-where modular product designs and simplified user interfaces reduce training burdens and enhance adoption.

Partnerships between manufacturers, sterilization service providers, and distributors are becoming increasingly strategic; collaborations that align product development with sterilization workflows and distribution logistics yield faster time-to-clinic and improved shelf-life management. In addition, value-added services-such as remote device monitoring, clinician training programs, and bundled consumable offerings-are shaping account-level competition. Firms that invest in demonstrating real-world outcomes and that can support institutional purchasers with credible implementation roadmaps are better positioned to secure long-term contracts and to defend against price-centric competition.

Practical, prioritized actions for manufacturers and providers to align product innovation, supply-chain resilience, and channel strategy for durable competitive advantage

Industry leaders should adopt a multifaceted approach that aligns product innovation with supply-chain resilience and go-to-market versatility. First, prioritize investments in membrane and device ergonomics that directly address clinician workflow and patient comfort in both in-center and home-care environments, thereby reducing adoption friction. Second, diversify sourcing and sterilization partnerships to build redundancy and to mitigate exposure to policy-driven cost shocks; cultivate regional manufacturing or tolling arrangements where commercially sensible to shorten lead times and improve responsiveness.

Third, strengthen commercial value propositions by coupling product performance evidence with service-level commitments, such as training curricula for assisted-home models and rapid-response logistics for hospital accounts. Fourth, rationalize distribution strategies to balance direct relationships with high-volume purchasers and digital channels that reach smaller providers and self-care consumers. Finally, embed regulatory intelligence and post-market evidence generation into product roadmaps, ensuring that clinical efficacy, safety reporting, and lifecycle management are prioritized in tandem with commercial milestones. Taken together, these steps create defensible positions and enhance the ability to capture value across diverse segments and regions.

A transparent, triangulated research methodology combining clinician interviews, regulatory and technical reviews, and scenario analysis to ensure robust and reproducible insights

This research synthesis blends primary and secondary intelligence with a disciplined methodology that emphasizes validation, triangulation, and reproducibility. Primary inputs included structured interviews with clinicians, procurement leaders, and distribution partners across major regions, combined with empirical reviews of regulatory filings, sterilization protocols, and manufacturing process documentation to ground technical assertions. Secondary inputs were derived from peer-reviewed literature on membrane performance, published guidance on dialysis best practices, and public policy documents related to trade and medical device regulation to contextualize strategic implications.

Analytical methods involved cross-segment triangulation to ensure that insights reflected consistent patterns across device types, end-user environments, and distribution channels. Scenario analysis was applied to assess operational responses to supply-chain disruptions and trade-policy changes, while sensitivity checks were used to validate qualitative conclusions against alternative assumptions. Wherever possible, evidence hierarchies were applied so that clinical claims cited higher-quality sources and operational observations drew upon multiple independent confirmations. This approach provides a defensible foundation for the recommendations and strategic observations presented herein.

A concise synthesis of key strategic conclusions highlighting why integrated product, supply-chain, and service approaches determine success in the evolving dialyzer market

In conclusion, polysulfone dialyzers remain a cornerstone of dialysis therapy because they harmonize proven clinical performance with manufacturing practicality. The market landscape is being reshaped by a confluence of forces: clinical demand for optimized clearance and biocompatibility, the migration of care into home environments, evolving distribution and sterilization practices, and policy-driven supply-chain adjustments. Organizations that align product innovation with evidence-based outcomes, invest in supply-chain resilience, and tailor distribution and training strategies for specific end-user contexts will be best positioned to win in this evolving environment.

As stakeholders evaluate future investments, the focus should be on integrated approaches that combine material and device improvements with service models that simplify adoption. In an environment where regulatory scrutiny, procurement expectations, and clinical protocols are continuously evolving, the ability to translate technical advantages into operational and financial value will determine sustained commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Polysulfone Dialyzer Market, by Dialyzer Type

  • 8.1. Conventional Dialyzers
    • 8.1.1. Low-Flux Dialyzers
    • 8.1.2. Medium-Flux Dialyzers
  • 8.2. High-Efficiency Dialyzers
    • 8.2.1. Standard Efficiency Dialyzers
    • 8.2.2. Ultra Efficiency Dialyzers
  • 8.3. High-Flux Dialyzers
    • 8.3.1. Standard High-Flux Dialyzers
    • 8.3.2. Super High-Flux Dialyzers

9. Polysulfone Dialyzer Market, by Sterilization Method

  • 9.1. Ethylene Oxide Sterilized
  • 9.2. Gamma Sterilized
    • 9.2.1. High Dose Gamma
    • 9.2.2. Low Dose Gamma
  • 9.3. Steam Sterilized

10. Polysulfone Dialyzer Market, by Membrane Configuration

  • 10.1. Flat Sheet
    • 10.1.1. Plate And Frame
    • 10.1.2. Spiral Wound
  • 10.2. Hollow Fiber
    • 10.2.1. Multi Lumen
    • 10.2.2. Single Lumen

11. Polysulfone Dialyzer Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Channels
  • 11.3. Third-Party Distributors
    • 11.3.1. Medical Equipment Suppliers
    • 11.3.2. Retail Pharmacies

12. Polysulfone Dialyzer Market, by End User

  • 12.1. Dialysis Centers
  • 12.2. Home Care Settings
    • 12.2.1. Assisted Home Care
    • 12.2.2. Self-Care
  • 12.3. Hospitals

13. Polysulfone Dialyzer Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Polysulfone Dialyzer Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Polysulfone Dialyzer Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Polysulfone Dialyzer Market

17. China Polysulfone Dialyzer Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Asahi Kasei Medical Co., Ltd.
  • 18.6. B. Braun Melsungen AG
  • 18.7. Baxter International Inc.
  • 18.8. Fresenius Medical Care AG & Co. KGaA
  • 18.9. Jafron Biomedical Co., Ltd.
  • 18.10. JMS Co., Ltd.
  • 18.11. MEDICA S.p.A.
  • 18.12. Nipro Corporation
  • 18.13. Nipro Corporation
  • 18.14. Poly Medicure Limited
  • 18.15. Terumo Corporation
  • 18.16. Toray Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POLYSULFONE DIALYZER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL POLYSULFONE DIALYZER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDIUM-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDIUM-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDIUM-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD EFFICIENCY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD EFFICIENCY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD EFFICIENCY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ULTRA EFFICIENCY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ULTRA EFFICIENCY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ULTRA EFFICIENCY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD HIGH-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD HIGH-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD HIGH-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SUPER HIGH-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SUPER HIGH-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SUPER HIGH-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ETHYLENE OXIDE STERILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ETHYLENE OXIDE STERILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ETHYLENE OXIDE STERILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH DOSE GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH DOSE GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH DOSE GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW DOSE GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW DOSE GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW DOSE GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STEAM STERILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STEAM STERILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STEAM STERILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY PLATE AND FRAME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY PLATE AND FRAME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY PLATE AND FRAME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SPIRAL WOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SPIRAL WOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SPIRAL WOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDICAL EQUIPMENT SUPPLIERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDICAL EQUIPMENT SUPPLIERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDICAL EQUIPMENT SUPPLIERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ASSISTED HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ASSISTED HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ASSISTED HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SELF-CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SELF-CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SELF-CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 233. GCC POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GCC POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 236. GCC POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 238. GCC POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 239. GCC POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 240. GCC POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 241. GCC POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 242. GCC POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 243. GCC POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. GCC POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 245. GCC POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GCC POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 275. G7 POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. G7 POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. G7 POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 278. G7 POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 279. G7 POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 280. G7 POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 281. G7 POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 282. G7 POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 283. G7 POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 284. G7 POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 285. G7 POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. G7 POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 287. G7 POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. G7 POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 289. NATO POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. NATO POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. NATO POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 292. NATO POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 293. NATO POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 294. NATO POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 295. NATO POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 296. NATO POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 297. NATO POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 298. NATO POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 299. NATO POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. NATO POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 301. NATO POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. NATO POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)

TABLE 3